Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAT6026 in moderate-to-severe atopic dermatitis
CTR20233045Phase 2Active
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- Jan 2024
- Modality
- Vaccines & Immunotherapeutics, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BAT6026 in atopic dermatitis (AD), sponsored by Bio-Thera Solutions, Ltd.. Started Jan 2024; status: active.
02
Drugs
BAT6026
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20233045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233045.